Yarrow Bioscience Insider Trades
NASDAQ: YARWHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Yarrow Bioscience insider activity
Over the last 12 months, Yarrow Bioscience insiders reported 18 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows RTW Fund Group GP, LLC & WONG RODERICK (10% Owner) reporting a transaction in 133,290 shares on Jul 29, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put YARW's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
YARW insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jul 29, 2026 | RTW Fund Group GP, LLC & WONG RODERICK10% Owner | other | 133,290 | — | Form 4 |
| Jul 23, 2026 | Stuart IainCHIEF SCIENTIFIC OFFICER | Tax withholding | 15,405 | $13.83K | Form 4 |
| Jul 23, 2026 | Zeronda TylerCHIEF FINANCIAL OFFICER | Tax withholding | 22,516 | $20.21K | Form 4 |
| Jul 23, 2026 | Domzalski DavidPRESIDENT AND CEO | Tax withholding | 79,391 | $71.26K | Form 4 |
| Jul 23, 2026 | Harsch MutyaCHIEF LEGAL OFFICER AND GC | Tax withholding | 22,516 | $20.21K | Form 4 |
| Jun 30, 2026 | Harsch MutyaCHIEF LEGAL OFFICER AND GC | Tax withholding | 3,464 | $2.25K | Form 4 |
| Jun 30, 2026 | Zeronda TylerCHIEF FINANCIAL OFFICER | Tax withholding | 3,464 | $2.25K | Form 4 |
| Jun 30, 2026 | Domzalski DavidPRESIDENT AND CEO | Tax withholding | 12,214 | $7.95K | Form 4 |
| Jun 30, 2026 | Stuart IainCHIEF SCIENTIFIC OFFICER | Tax withholding | 2,370 | $1.54K | Form 4 |
| May 29, 2026 | Domzalski DavidPRESIDENT AND CEO | Award | 30,791 | $9.55K | Form 4 |
| Mar 31, 2026 | Domzalski DavidPRESIDENT AND CEO | Tax withholding | 14,232 | $8.50K | Form 4 |
| Mar 31, 2026 | Harsch MutyaCHIEF LEGAL OFFICER AND GC | Tax withholding | 4,007 | $2.39K | Form 4 |
| Mar 31, 2026 | Stuart IainCHIEF SCIENTIFIC OFFICER | Tax withholding | 2,876 | $1.72K | Form 4 |
| Mar 31, 2026 | Zeronda TylerCHIEF FINANCIAL OFFICER | Tax withholding | 4,007 | $2.39K | Form 4 |
| Dec 31, 2025 | Harsch MutyaCHIEF LEGAL OFFICER AND GC | Tax withholding | 3,579 | $2.08K | Form 4 |
| Dec 31, 2025 | Stuart IainCHIEF SCIENTIFIC OFFICER | Tax withholding | 2,448 | $1.42K | Form 4 |
| Dec 31, 2025 | Zeronda TylerCHIEF FINANCIAL OFFICER | Tax withholding | 7,858 | $4.56K | Form 4 |
| Dec 31, 2025 | Domzalski DavidPRESIDENT AND CEO | Tax withholding | 12,684 | $7.36K | Form 4 |
| Sep 30, 2025 | Domzalski DavidPRESIDENT AND CEO | Tax withholding | 12,676 | $4.25K | Form 4 |
| Sep 30, 2025 | Harsch MutyaCHIEF LEGAL OFFICER AND GC | Tax withholding | 3,581 | $1.20K | Form 4 |
| Sep 30, 2025 | Stuart IainCHIEF SCIENTIFIC OFFICER | Tax withholding | 2,453 | $821.76 | Form 4 |
| Sep 30, 2025 | Zeronda TylerCHIEF FINANCIAL OFFICER | Tax withholding | 3,420 | $1.15K | Form 4 |
| Jun 30, 2025 | Domzalski DavidPRESIDENT AND CEO | Tax withholding | 12,676 | $20.92K | Form 4 |
| Jun 30, 2025 | Zeronda TylerCHIEF FINANCIAL OFFICER | Tax withholding | 3,420 | $5.64K | Form 4 |
| Jun 30, 2025 | Harsch MutyaCHIEF LEGAL OFFICER AND GC | Tax withholding | 3,581 | $5.91K | Form 4 |
| Jun 30, 2025 | Stuart IainCHIEF SCIENTIFIC OFFICER | Tax withholding | 2,453 | $4.05K | Form 4 |
| Jun 2, 2025 | Harsch MutyaCHIEF LEGAL OFFICER AND GC | Award | 1,145 | $927.45 | Form 4 |
| Jun 2, 2025 | Domzalski DavidPRESIDENT AND CEO | Award | 8,681 | $7.03K | Form 4 |
| Mar 31, 2025 | Harsch MutyaCHIEF LEGAL OFFICER AND GC | Tax withholding | 8,828 | $13.95K | Form 4 |
| Mar 31, 2025 | Domzalski DavidPRESIDENT AND CEO | Tax withholding | 30,498 | $48.19K | Form 4 |
| Mar 31, 2025 | Stuart IainCHIEF SCIENTIFIC OFFICER | Tax withholding | 6,044 | $9.55K | Form 4 |
| Mar 31, 2025 | Zeronda TylerCHIEF FINANCIAL OFFICER | Tax withholding | 8,399 | $13.27K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4